FDA proposes new policy for diagnostic and radiology devices
The Food and Drug Administration issued a draft guidance last month describing its intent to exercise enforcement discretion regarding premarket notification for certain in vitro diagnostic and radiology devices with established safety and effectiveness records. The guidance lists 30 different device types, including common urine and blood tests, and such radiology device accessories as film cassettes, film processors and digitizers.
»Click here for more information.
Related Articles
NFPA weekly update: Jan. 20-24
Committee revisions and comments on the second draft of the 2026 edition of NFPA 25 have been posted.
ASHRAE guidelines and standards open for comment
A list of ASHRAE addenda, revisions and drafts affecting health care open for public comment.
NFPA weekly update: Jan. 13-17
The committee for the 2026 edition of NFPA 70, National Electrical Code, wrapped up public input review and voting on the code's second draft..